Dae Ho Cho
15Patents
2h-index
28Co-inventors
50Inventor score
Filing activity: Nov 11, 2009 → Jan 3, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10188694B2 | Peptide for skin regeneration or wound treatment and use thereof | Human Necessities | 3 | Active |
| US8576159B2 | Driving method for local dimming of liquid crystal display device and apparatus using the same | Physics | 2 | Active |
| US9610318B2 | Peptides for promoting angiogenesis and use thereof | Chemistry; Metallurgy | 1 | Active |
| US10206969B2 | Peptide for preventing or treating inflammatory diseases and use thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US10213475B2 | Peptide for preventing or treating inflammatory diseases and use thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US9938320B2 | Peptides for promoting angiogenesis and use thereof | Chemistry; Metallurgy | 1 | Active |
| US9403874B2 | Peptides and use thereof | Human Necessities | 0 | Active |
| US8350798B2 | Liquid crystal display device | Physics | 0 | Active |
| US11730788B2 | Use of peptides as therapeutic agent for autoimmune diseases and bone diseases | Emerging Cross-Sectional Technologies | 0 | Active |
| US9249185B2 | Peptides for promoting angiogenesis and an use thereof | Human Necessities | 0 | Active |
| US11648286B2 | Use of peptides as therapeutic agent for autoimmune diseases and bone diseases | General | 0 | Revoked |
| US10913771B2 | Peptide for preventing or treating inflammatory diseases and use thereof | Human Necessities | 0 | Active |
| US11629169B2 | Use of peptides as therapeutic agent for autoimmune diseases and bone diseases | Emerging Cross-Sectional Technologies | 0 | Active |
| US10995117B2 | Peptide for skin regeneration or wound treatment and use thereof | Chemistry; Metallurgy | 0 | Active |
| US10913772B2 | Peptide for preventing or treating inflammatory diseases and use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.